IDDI, Your Partner to Accelerate Your Clinical Trials in Rare Diseases
Clinical studies in rare diseases need a CRO with specific strategies regarding site selection, patient enrollment, and retention. They require special expertise in designing protocols, executing clinical trial design for a sparse and often widely distributed population as well as the understanding of the regulatory constraints of orphan status. When conducting clinical trials in orphan diseases, sponsors face medical, scientific and operational challenges.
Experience in Rare Diseases
Having conducted 72 studies in Orphan Diseases, we understand those challenges and have the expertise to help you successfully develop orphan drugs.
- Our regulatory and scientific expertise help to ensure the best designs for orphan diseases studies
- We can assist you with site selection, logistics, data management and operational strategy
- We bring together deep therapeutic experience, extensive knowledge of historical data registry and market access, and regulatory consulting
- Our statistical experts are able to implement methods to analyze clinical trials involving small patient numbers
Our experience includes 70+ rare diseases clinical studies in a broad range of indications: